Epithelial expression of caveolin‐2, but not caveolin‐1, is enhanced in the inflamed mucosa of patients with ulcerative colitis

Caveolae are vesicular invaginations of the plasma membrane that act as a scaffold of the assembly of many classes of signaling molecules. Caveolins are the principal structural component of caveolae membranes, and three distinct forms of caveolins have been identified: caveolin‐1, caveolin‐2, and caveolin‐3. In this study, we evaluated the changes in the caveolin‐1 and caveolin‐2 expression in the inflamed mucosa of patients with IBD. Tissue samples were obtained endoscopically from patients with ulcerative colitis (UC) (n = 18), Crohn's disease (n = 10) and ischemic colitis (n = 8). Normal colorectal tissues were also obtained (n = 15). The caveolin expression was evaluated by standard immunohistochemical procedure. In normal colonic mucosa, caveolin‐1 expression was detected in the smooth‐muscle cells of the muscularis mucosae and the endothelial cells, but caveolin‐2 expression was not detected. In the inflamed mucosa of patients with active UC, caveolin‐2 expression was clearly detectable as small scattered foci on the luminal surfaces of epithelial cells, but caveolin‐1 expression was similar to that in normal mucosa. Caveolin‐2 expression increased in accordance with the disease activity of UC. This enhanced caveolin‐2 expression was not detected in active Crohn's disease or ischemic colitis. In conclusion, we demonstrated that the epithelial expression of caveolin‐2 is markedly enhanced in the inflamed mucosa of patients with UC. It is likely that the enhanced caveolin‐2 expression in patients with UC was associated with the altered signal transductions in the intestinal epithelial cells. Furthermore, our results suggest that there are differences in the phenotypic features of epithelial cells between UC and Crohn's disease.